ME Newswire / Business Wire CHARLOTTE, N.C. - Tuesday, January 29th 2013 Previously Announced Selected Items Impact Pretax Earnings Representations and Warranties, Compensatory Fees Settlements with Fannie Mae, $2.7 Billion or $0.16 EPS Provision for Independent Foreclosure Review Acceleration Agreement, $1.1 Billion or $0.06 EPS Total Litigation Expense, $0.9 Billion or $0.05 EPS Negative Valuation Adjustments for Improved Credit Spreads, $0.7 Billion or $0.04 EPS Provision for Obligations Related to Mortgage Insurance Rescissions, $0.5 Billion or $0.03 EPS Gain on Sale of Japan Brokerage Joint Venture, $0.4 Billion or $0.02 EPS Positive MSR Valuation Adjustment Related to Servicing Sales, $0.3 Billion or $0.02 EPS Net Tax Benefit Primarily From Recognition of Foreign Tax Credits of Certa
...
Read more »
|
Dubai, United Arab Emirates - Tuesday, January 29th 2013 [ME NewsWire] (BUSINESS WIRE)-- Yardi Systems, a leading developer of software solutions for the real estate investment, asset and property management industry, is pleased to announce the opening of a new office in Dubai, United Arab Emirates. The Dubai office will be a hub for regional business development, project management, and consulting as well as training and technical support services. Following strong growth and demand for solutions and services across the Middle East, Neal Gemassmer, vice president of Yardi Asia Pacific & Middle East, comments, "We have seen tremendous demand by the market for more integrated real estate solutions. This is an exciting phase in Yardi’s development in the region; we have maintained a strong, focused path, driven by our commitment to our clients in the Middle East. This next phase of development will enable us to further broaden and deepen the range of solutions and suppo
...
Read more »
|
Low drop-out, low output noise and high-speed load transient response achieved in an ultra-small package TOKYO - Tuesday, January 29th 2013 [ME NewsWire] (BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) has expanded its line-up of 200mA single output CMOS-LDO regulators for mobile devices with low drop-out, low output noise and high-speed load transient response characteristics. By using the latest generation micro-CMOS process, the new lineup, the TCR2EN, TCR2EE and TCR2EF series, achieves high performance characteristics required in analog circuits in an ultra-small package. In addition to the ultra-small 0.8 x 0.8 x 0.38mm package (SDFN4), the new lineup includes the ESV (SOT-553: 1.6 x 1.6 x 0.55mm) and SMV (SOT-25: 2.9 x 2.8 x 1.1 mm) general-purpose packages. The device line-up covers a range of voltage-clamp type output voltages, from 1.0V to 5.0V. The new CMOS-LDO regulators are suitable for use in a wide range of mobile devices, such as smart
...
Read more »
|
Global awards programme recognises innovators enabling urban progress NEW YORK - Monday, January 28th 2013 [ME NewsWire] Submissions accepted until March 31, 2013 (BUSINESS WIRE)-- Today, the Financial Times and Citi announce a global call for submissions for the 2013 FT/Citi Ingenuity Awards: Urban Ideas in Action, a global programme that will recognise individuals, teams, organisations and community groups that have developed groundbreaking solutions to urban challenges that benefit cities, citizens and urban communities. With more than 3.3 billion people currently living in urban areas – a number expected to rise to over 5 billion by 2030, according to a United Nations report – cities have a pressing need to address accelerating urbanisation to continue to thrive. This global programme was developed by the FT and Citi, in collaboration with INSEAD, to recognise those fueling urban progress. What’s New for 2013 In 2013, the FT/Citi Ingenuity
...
Read more »
|
SANTA ANA, Calif. - Monday, January 28th 2013 [ME NewsWire] (BUSINESS WIRE)-- MP Biomedicals, LLC announced today that it has submitted a BLA for FDA approval of the MP Diagnostics HTLV Blot 2.4, a Western blot for confirmatory testing and viral typing of blood donors and patients. Additionally, MP Biomedicals plans to initiate an open IND study in February, which will allow for investigational use (IUO) of the assay on donor and patient samples while the product is under FDA evaluation. The American Red Cross is among the study participants. U.S. labs interested in participating may contact Karen Luthart for more information (see above). "The HTLV Blot 2.4 represents a significant milestone for our company and it will be the first licensed confirmatory test for donor notification and counseling of HTLV infections in the U.S.,” said Milan Panic, Founder and Chief Executive Officer of MP Biomedicals. The assay is currently CE Marked and registered as a diagnostic de
...
Read more »
|
THOUSAND OAKS, Calif. & ESPOO, Finland - Monday, January 28th 2013 [ME NewsWire] (BUSINESS WIRE)-- Rightware, the leader in user interface (UI) design and implementation software, and RKS, the leading strategic design consultancy based in Southern California, announce that they have formed a partnership in Interaction Design for new and emerging markets including entertainment, tablets, smart TVs and other embedded verticals. Today is an unprecedented time for technology and user interaction. Touch screens are becoming a more and more predominant way of interacting. And with the vast amount of choices, there remains room and opportunity to create even more engaging and dynamic interfaces: from cars to phones, tablets and computers. What a person sees, feels and touches can be enriched into something he or she has never seen or engaged with before. This is an era where design, technology and understanding of human behavior come together; but a deep understanding
...
Read more »
|
Announced to coincide with the Personalized Medicine World Conference (PMWC 2013), Silicon Valley, CA LONDON - Monday, January 28th 2013 [BUSINESS WIRE/ ME NewsWire] Inventages (a global healthcare venture capital fund backed by Nestlé) announced today that they are working with SAP AG to integrate a comprehensive and mechanism-based approach to disease management with best-in-class IT frameworks to develop the next generation of personalized medicine companies. Personalized medicine uses genetic and non-genetic information, such as environmental factors, to individualize the prevention, diagnosis, and treatment of disease. However to date, these solutions have typically been fragmented and incomplete, only addressing a subset of influencing factors. The personalized medicine solutions of the future will be holistic; integrating a patient’s genomic information, medical history, environmental and lifestyle factors. This holistic approach to managing disease
...
Read more »
| |